- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 15/66 - General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligationUse of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
Patent holdings for IPC class C12N 15/66
Total number of patents in this class: 921
10-year publication summary
54
|
89
|
117
|
126
|
86
|
90
|
70
|
62
|
64
|
41
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Regeneron Pharmaceuticals, Inc. | 4233 |
40 |
Shenzhen Biocan Technologies Co., Ltd. | 147 |
34 |
Twist Bioscience Corporation | 237 |
28 |
Gen9, Inc. | 71 |
18 |
Wisconsin Alumni Research Foundation | 3864 |
15 |
The Regents of the University of California | 19839 |
13 |
Massachusetts Institute of Technology | 10019 |
12 |
Generation Bio Co. | 148 |
11 |
Agilent Technologies, Inc. | 2634 |
10 |
New England BioLabs, Inc. | 489 |
9 |
Telesis Bio Inc. | 60 |
9 |
Integrated DNA Technologies, Inc. | 273 |
8 |
University of Washington | 2315 |
8 |
University of Massachusetts | 2222 |
7 |
The Trustees of the University of Pennsylvania | 4315 |
6 |
University of Florida Research Foundation, Inc. | 3994 |
6 |
Caribou Biosciences, Inc. | 142 |
6 |
Jiangnan University | 1517 |
6 |
Oxford University Innovation Limited | 1503 |
6 |
Lifeedit Therapeutics, Inc. | 55 |
6 |
Other owners | 663 |